NO933611L - Anti-tumor- og anti-psoriatiske midler - Google Patents

Anti-tumor- og anti-psoriatiske midler

Info

Publication number
NO933611L
NO933611L NO93933611A NO933611A NO933611L NO 933611 L NO933611 L NO 933611L NO 93933611 A NO93933611 A NO 93933611A NO 933611 A NO933611 A NO 933611A NO 933611 L NO933611 L NO 933611L
Authority
NO
Norway
Prior art keywords
tumor
psoriatic agents
compounds
agents
psoriatic
Prior art date
Application number
NO93933611A
Other languages
English (en)
Norwegian (no)
Other versions
NO933611D0 (no
Inventor
Stuart W Mccombie
Bandarpalle B Shankar
Michael P Kirkup
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO933611L publication Critical patent/NO933611L/no
Publication of NO933611D0 publication Critical patent/NO933611D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO933611A 1991-04-11 1993-10-08 Anti-tumor- og anti-psoriatiske midler NO933611D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68377091A 1991-04-11 1991-04-11
PCT/US1992/002661 WO1992018507A1 (en) 1991-04-11 1992-04-09 Anti-tumor and anti-psoriatic agents

Publications (2)

Publication Number Publication Date
NO933611L true NO933611L (no) 1993-10-08
NO933611D0 NO933611D0 (no) 1993-10-08

Family

ID=24745378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933611A NO933611D0 (no) 1991-04-11 1993-10-08 Anti-tumor- og anti-psoriatiske midler

Country Status (14)

Country Link
EP (2) EP0508792A1 (cs)
JP (1) JPH06503837A (cs)
CA (1) CA2108146A1 (cs)
CZ (1) CZ213693A3 (cs)
FI (1) FI934461A0 (cs)
HU (1) HUT70187A (cs)
IE (1) IE921148A1 (cs)
IL (1) IL101554A0 (cs)
MX (1) MX9201643A (cs)
NO (1) NO933611D0 (cs)
NZ (1) NZ242294A (cs)
SK (1) SK108293A3 (cs)
TW (1) TW214553B (cs)
WO (1) WO1992018507A1 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
DE69326388T2 (de) * 1992-06-22 1999-12-30 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur Herstellung von Staurosporin-Derivaten
WO1994007895A1 (en) * 1992-09-25 1994-04-14 Schering Corporation Diindolo compounds and pharmaceutical compositions containing them
US5723456A (en) * 1993-12-07 1998-03-03 Eli Lilly & Company Therapeutic treatment for cardiovascular diseases
ES2162843T3 (es) * 1993-12-07 2002-01-16 Lilly Co Eli Inhibidores de la proteina quinasa c.
US5843935A (en) * 1993-12-07 1998-12-01 Eli Lilly And Company Protein kinase C inhibitors
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
AU1911095A (en) * 1994-02-18 1995-09-04 Cephalon, Inc. Aqueous indolocarbazole solutions
AU6657596A (en) * 1995-07-31 1997-02-26 Ciba-Geigy Ag Trindene compounds
US20040037828A1 (en) * 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
FR2826653B1 (fr) * 2001-06-29 2005-10-14 Servier Lab Nouveaux derives de pyrido-pyrido-pyrrolo[3,2-g]pyrrolo [3,4-e]-indole et pyrido-pyrrolo[2,3-a]pyrrolo[3,4-c] carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
WO2005013885A2 (en) 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
EP2452686A3 (en) 2005-08-29 2012-09-05 HealOr Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
EP2181999A1 (en) 2008-11-03 2010-05-05 Zentiva, A.S. Method of manufacturing ruboxistarin
WO2011083482A2 (en) 2010-01-11 2011-07-14 Healor Ltd. Method for treatment of psoriasis
EP3169337A1 (en) 2014-07-17 2017-05-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923986A (en) * 1987-03-09 1990-05-08 Kyowa Hakko Kogyo Co., Ltd. Derivatives of physiologically active substance K-252
DE3924538A1 (de) * 1989-07-25 1991-01-31 Goedecke Ag Indolocarbazol und dessen verwendung

Also Published As

Publication number Publication date
FI934461L (fi) 1993-10-11
AU646163B2 (en) 1994-02-10
TW214553B (cs) 1993-10-11
IL101554A0 (en) 1992-12-30
FI934461A7 (fi) 1993-10-11
NZ242294A (en) 1993-07-27
FI934461A0 (fi) 1993-10-11
EP0580812A1 (en) 1994-02-02
NO933611D0 (no) 1993-10-08
MX9201643A (es) 1992-10-01
CZ213693A3 (en) 1994-05-18
EP0508792A1 (en) 1992-10-14
HU9302869D0 (en) 1993-12-28
SK108293A3 (en) 1994-09-07
CA2108146A1 (en) 1992-10-12
HUT70187A (en) 1995-09-28
IE921148A1 (en) 1992-10-21
JPH06503837A (ja) 1994-04-28
WO1992018507A1 (en) 1992-10-29
AU1798292A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
NO933611L (no) Anti-tumor- og anti-psoriatiske midler
MD1224C2 (ro) Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B
DK0564924T3 (da) 2-Oxoethylderivater som immunosuppressiva
ES2082780T3 (es) Derivados de acido bisfosfonico heterociclicos.
NO996108L (no) 9-oksinerytromycinderivater
SE8900192D0 (sv) Dideoxididehydrokarbocykliska nukleosider
CA2040982A1 (en) N-(3-fluoro-2-phosphonylmethoxypropyl) derivatives of purine and pyrimidine heterocyclic bases, their preparation and use
NO982987L (no) Amidinoproteasehemmere
NO923721D0 (no) 4-desoksy-4-epipodophyllotoxin-derivat eller farmasoeytiskakseptabelt salt derav
ATE81653T1 (de) Dideoxydidehydrocarbocyclische nukleoside.
JO1704B1 (en) New potent compounds
NO178968C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
PT861250E (pt) Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase
NO922114L (no) Kjemiske forbindelser
AU614204B2 (en) 16-hydroxymethyl amphotericin b derivatives
MX9804828A (es) Benzotiazolona etanaminas biologicamente activas.
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
MX9206930A (es) Nuevos compuestos
DE69828390D1 (de) Diaminotrifluoromethylpyrimidinderivate enthaltende antikrebs-zusammensetzung
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
NO974651L (no) Biologisk aktive ureidoderivater som er nyttige i behandlingen av multippel sklerose
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
ES2134971T3 (es) Derivado de acido octahidro-2-naftaleno-carboxilico, su produccion y uso.
KR970702869A (ko) 항종양성 인돌로피롤로카르바졸 유도체(antitumor indolopyprolocarbazole derivative)
NO851206L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme 1,4-dihydropyridiner